Symbols Screeners Learn Open terminal

Language

Symbols

AAPL
MSFT
GOOGL
AMZN
NVDA
META
TSLA
AVGO

Screeners

RSI oversold — S&P 500
RSI oversold — NASDAQ-100 heavy
Volume spike breakouts
Mega-cap momentum

Strategies

Wyckoff
ICT
Smart money concepts
Chart patterns

Trust & methodology

Screener methodology
Signal methodology
Backtest methodology
Editorial standards
Corrections log
About Drogo Research

Drogo

For informational purposes only. Not investment advice. Trading involves substantial risk of loss. Past performance does not guarantee future results.

Trading involves risk. Nothing on this site is investment advice.

ABBVIE INC. (ABBV) — quote, chart, RSI | Drogo

Drogo
Symbols
ABBV

ABBV (ABBV)

Last updated: Oct 30, 2026 · NYSE

Snapshot

Last close: $294.89
Change: +1.41%
52-week range: $190.75 – $298.74
RSI (14): 73.2 · Overbought

FAQ

What is ABBV?
ABBVIE INC.
RSI (14) right now
73.2 — overbought. What does this mean?
Open in terminal
Launch charts for ABBV

Recent ABBV news

Better Dividend ETF: iShares HDV's High Yields vs. ProShares NOBL's Dividend Growth
The Motley Fool · Oct 31, 2026
ABBV Beats on Q3 Earnings & Sales, Stock Rises on Raised '26 EPS View
Zacks Investment Research · Oct 30, 2026
Pre-Markets in Red on Massive AI Spending Concerns
Zacks Investment Research · Oct 30, 2026
Pre-Markets Spooked on Questions Regarding AI, Oil Prices
Zacks Investment Research · Oct 30, 2026
Here's What Key Metrics Tell Us About AbbVie (ABBV) Q3 Earnings
Zacks Investment Research · Oct 30, 2026
AbbVie (ABBV) Tops Q3 Earnings and Revenue Estimates
Zacks Investment Research · Oct 30, 2026

Open terminal Today's brief RSI oversold S&P 500 Methodology

Ask Drogo about this:

Related symbols

USDILS
^GSPC
^IXIC
^DJI
^RUT
^VIX

Drogo Research — Quant editorial

Reviewed for factual accuracy; methodology linked below.